2026 Metastatic Breast Cancer: Practice-Changing Highlights from International Meetings
CME Events
This activity is designed to efficiently discuss recent clinical advances in breast cancer oncology that have emerged from presentations at recent international meetings including ASCO and SABCS. The activity format will provide opportunity for interaction between Penn Medicine faculty and meeting attendees with the aim of implementing new standards of patient care. Participants will gain up-to-date, practical information with immediate clinical application.
Type of Event: CME Course. Conference. Learning Objectives: At the completion of this course, participants should be able to: Evaluate recent trial data and FDA approvals for ER+, HER2-negative, and HER2-positive metastatic breast cancer. , Integrate emerging targeted agents and ADCs into treatment algorithms for metastatic TNBC. , Assess the impact of new therapies on current standards of care to improve patient outcomes. , Apply multidisciplinary perspectives to complex clinical scenarios during evidence-based panel discussions. Accreditation: In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Designation of Credit: Physicians: Penn Medicine designates this live activity for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: This program provides 1.75 NCPD Hours. Disclosures: Penn Medicine, Office of Continuing Medical and Interprofessional Education, adheres to the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty and planner’s disclosure information will be made available in the conference materials and syllabus. Faculty members are also expected to disclose to participants any discussion of off-label and/or investigational use of pharmaceutical products or devices within their presentations.
Wednesday, April 8, 2026, 5:45 PM – 7:50 PM.
VIRTUAL.
IN PERSON- Updates in Oncology 2026 Philadelphia: with Proceedings from International Medical Meetings
CME Events
Type of Event: CME Course. Conference. Who Should Attend: This activity has been designed for medical, surgical and radiation oncologists, hematologists/oncologists, hematology/oncology fellows, radiologists, neurological surgeons, thoracic surgeons, urologists, gastroenterologists, pulmonologists, dermatologists, oncology nurses, and other healthcare professionals involved in the treatment of patients with cancer. Learning Objectives: Upon completion of this conference, participants should be able to: Evaluate recent clinical data to optimize the selection of therapies for leukemia, lymphoma, and multiple myeloma. , Incorporate evidence-based updates for breast, gastrointestinal, and lung cancers into clinical practice. , Identify recent therapeutic advances and evolving standards of care for genitourinary (GU) malignancies. , Integrate novel treatment protocols into the management of patients with melanoma. , Assess clinical… Accreditation: In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Designation of Credit: PHYSICIANS: Penn Medicine designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NURSES: This program awards 3.25 NCPD hours.
PHYSICIAN ASSISTANTS: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of … Disclosures: Penn Medicine, Office of Continuing Medical and Interprofessional Education, adheres to the ACCME Standards for Commercial Support. Faculty and planner’s disclosure information will be made available in the conference materials and syllabus. Faculty members are also expected to disclose to participants any discussion of off-label and/or investigational use of pharmaceutical products or devices within their presentations.
Wednesday, June 10, 2026, 5:00 PM – 9:15 PM.
In Person at The Hilton Philadelphia.
VIRTUAL - Updates in Oncology 2026 Philadelphia: with Proceedings from International Medical Meetings
CME Events
Type of Event: CME Course. Conference. Who Should Attend: This activity has been designed for medical, surgical and radiation oncologists, hematologists/oncologists, hematology/oncology fellows, radiologists, neurological surgeons, thoracic surgeons, urologists, gastroenterologists, pulmonologists, dermatologists, oncology nurses, and other healthcare professionals involved in the treatment of patients with cancer. Learning Objectives: Upon completion of this conference, participants should be able to: Evaluate recent clinical data to optimize the selection of therapies for leukemia, lymphoma, and multiple myeloma. , Incorporate evidence-based updates for breast, gastrointestinal, and lung cancers into clinical practice. , Identify recent therapeutic advances and evolving standards of care for genitourinary (GU) malignancies. , Integrate novel treatment protocols into the management of patients with melanoma. , Assess clinical… Accreditation: In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Designation of Credit: PHYSICIANS: Penn Medicine designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NURSES: This program awards 3.25 NCPD hours.
PHYSICIAN ASSISTANTS: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of … Disclosures: Penn Medicine, Office of Continuing Medical and Interprofessional Education, adheres to the ACCME Standards for Commercial Support. Faculty and planner’s disclosure information will be made available in the conference materials and syllabus. Faculty members are also expected to disclose to participants any discussion of off-label and/or investigational use of pharmaceutical products or devices within their presentations.
Wednesday, June 10, 2026, 5:00 PM – 9:15 PM.
Virtually.
**Exhibitors In Person ONLY** Updates in Oncology 2026 with Proceedings from International Medical Meetings
Penn Cancer CME Events
Type of Event: Conference.
Wednesday, June 10, 2026, 5:00 PM – 9:30 PM.
Hilton Philadelphia City Avenue
4200 City Avenue, Philadelphia, PA, 19131.
For more info visit www.med.upenn.edu.